245 related articles for article (PubMed ID: 10582875)
1. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Shawar RM; MacLeod DL; Garber RL; Burns JL; Stapp JR; Clausen CR; Tanaka SK
Antimicrob Agents Chemother; 1999 Dec; 43(12):2877-80. PubMed ID: 10582875
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Pseudomonas aeruginosa from bacteremic and fibrocystic patients to four quinolones and five other antipseudomonal antibiotics.
Lester A; Andreasen JJ
Scand J Infect Dis; 1988; 20(5):525-9. PubMed ID: 3146807
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
Strateva T; Petrova G; Mitov I
J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
[TBL] [Abstract][Full Text] [Related]
4. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.
MacLeod DL; Nelson LE; Shawar RM; Lin BB; Lockwood LG; Dirk JE; Miller GH; Burns JL; Garber RL
J Infect Dis; 2000 Mar; 181(3):1180-4. PubMed ID: 10720551
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.
Aronoff SC; Klinger JD
J Antimicrob Chemother; 1985 May; 15(5):545-9. PubMed ID: 3924879
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Ansorg R; Müller KD; Wiora J
Chemotherapy; 1990; 36(3):222-9. PubMed ID: 2110878
[TBL] [Abstract][Full Text] [Related]
7. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
Ronco E; Vacheron F; Orabona A
Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
[TBL] [Abstract][Full Text] [Related]
8. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Scribner RK; Marks MI; Weber AH; Tarpay MM; Welch DF
Antimicrob Agents Chemother; 1982 Jun; 21(6):939-43. PubMed ID: 6810757
[TBL] [Abstract][Full Text] [Related]
9. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
[TBL] [Abstract][Full Text] [Related]
10. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
Millar BC; Rendall JC; Downey DG; Moore JE
J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
[TBL] [Abstract][Full Text] [Related]
11. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
Wu YL; Scott EM; Po AL; Tariq VN
APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Hurley JC; Miller GH; Smith AL
Diagn Microbiol Infect Dis; 1995 Aug; 22(4):331-6. PubMed ID: 8582138
[TBL] [Abstract][Full Text] [Related]
13. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa.
Lang BJ; Aaron SD; Ferris W; Hebert PC; MacDonald NE
Am J Respir Crit Care Med; 2000 Dec; 162(6):2241-5. PubMed ID: 11112146
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.
McNeill WF; John JF; Twitty JA
Am J Clin Pathol; 1984 Jun; 81(6):742-7. PubMed ID: 6428216
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany.
Schülin T
J Antimicrob Chemother; 2002 Feb; 49(2):403-6. PubMed ID: 11815589
[TBL] [Abstract][Full Text] [Related]
17. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
Fernandes CJ; Stevens DA; Ackerman VP
Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of a E-test method to detect bactericidy of beta lactam-aminoglycoside associations against Pseudomonas aeruginosa isolates from cystic fibrosis].
Massoni-Cristante S; Loiez C; Adriensen B; Husson MO
Pathol Biol (Paris); 2003 Apr; 51(3):135-42. PubMed ID: 12781793
[TBL] [Abstract][Full Text] [Related]
19. Genomic and phenotypic comparison of environmental and patient-derived isolates of
Ramsay KA; Wardell SJT; Patrick WM; Brockway B; Reid DW; Winstanley C; Bell SC; Lamont IL
J Med Microbiol; 2019 Nov; 68(11):1591-1595. PubMed ID: 31553303
[TBL] [Abstract][Full Text] [Related]
20. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
Field TR; White A; Elborn JS; Tunney MM
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
